{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:27Z","timestamp":1761100707559},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,7,26]],"date-time":"2004-07-26T00:00:00Z","timestamp":1090800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,7,26]],"date-time":"2004-07-26T00:00:00Z","timestamp":1090800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,9,1]]},"DOI":"10.1038\/sj.bmt.1704594","type":"journal-article","created":{"date-parts":[[2004,7,26]],"date-time":"2004-07-26T09:05:34Z","timestamp":1090832734000},"page":"425-431","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes"],"prefix":"10.1038","volume":"34","author":[{"given":"J P","family":"Uberti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Ayash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Ratanatharathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,7,26]]},"reference":[{"key":"BF1704594_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/sj.bmt.1701331","volume":"22","author":"P Jacobson","year":"1998","unstructured":"Jacobson P, Uberti J, Davis W, Ratanatharathorn V . Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation. Bone Marrow Transplant 1998; 22: 217\u2013225.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704594_CR2","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1182\/blood.V87.8.3514.bloodjournal8783514","volume":"87","author":"JW Fay","year":"1996","unstructured":"Fay JW, Wingard JR, Antin JH et al. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogeneic bone marrow transplantation. Blood 1996; 87: 3514\u20133519.","journal-title":"Blood"},{"key":"BF1704594_CR3","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V85.12.3746.bloodjournal85123746","volume":"85","author":"RA Nash","year":"1995","unstructured":"Nash RA, Etzioni R, Storb R et al. Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft versus host disease after marrow transplantation from HLA-matched siblings: a single-center study. Blood 1995; 85: 3746\u20133753.","journal-title":"Blood"},{"key":"BF1704594_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/sj.bmt.1700813","volume":"19","author":"JP Uberti","year":"1997","unstructured":"Uberti JP, Silver SM, Adams PT et al. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1997; 19: 1233\u20131238.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704594_CR5","first-page":"2303","volume":"92","author":"V Ratanatharathorn","year":"1998","unstructured":"Ratanatharathorn V, Nash RA, Przepiorka D et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 1998; 92: 2303\u20132314.","journal-title":"Blood"},{"key":"BF1704594_CR6","first-page":"2062","volume":"96","author":"RA Nash","year":"2000","unstructured":"Nash RA, Antin JH, Karanes C et al. Phase III study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96: 2062\u20132068.","journal-title":"Blood"},{"key":"BF1704594_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","volume":"28","author":"A Hiraoka","year":"2001","unstructured":"Hiraoka A, Ohashi Y, Okamoto S et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28: 181\u2013185.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704594_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1053\/bbmt.1999.v5.pm10392964","volume":"5","author":"MH Horowitz","year":"1999","unstructured":"Horowitz MH, Przepiorka D, Bartels P et al. Tacrolimus vs cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. Biol Blood Marrow Transplant 1999; 5: 180\u2013186.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704594_CR9","first-page":"25","volume":"3","author":"SM Devine","year":"1997","unstructured":"Devine SM, Geller RB, Lin LB et al. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. Biol Blood Marrow Transplant 1997; 3: 25\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704594_CR10","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood.V88.11.4383.4383","volume":"88","author":"D Przepiorka","year":"1996","unstructured":"Przepiorka D, Ippoliti C, Khouri I et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation. Blood 1996; 88: 4383\u20134389.","journal-title":"Blood"},{"key":"BF1704594_CR11","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/00007890-199612270-00022","volume":"62","author":"D Przepiorka","year":"1996","unstructured":"Przepiorka D, Ippoliti C, Khouri I et al. Allogeneic transplantation for advanced leukemia. Transplantation 1996; 62: 1806\u20131810.","journal-title":"Transplantation"},{"key":"BF1704594_CR12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","volume":"84","author":"V Ratanatharathorn","year":"1994","unstructured":"Ratanatharathorn V, Uberti J, Karanes C et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 1994; 84: 1050\u20131055.","journal-title":"Blood"},{"key":"BF1704594_CR13","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","volume":"70","author":"PJ Tutschka","year":"1987","unstructured":"Tutschka PJ, Copelan EA, Klein JP . Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382\u20131388.","journal-title":"Blood"},{"key":"BF1704594_CR14","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1200\/JCO.1996.14.5.1447","volume":"14","author":"WI Bensinger","year":"1996","unstructured":"Bensinger WI, Rowley SD, Demirer T et al. High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. J Clin Oncol 1996; 14: 1447\u20131456.","journal-title":"J Clin Oncol"},{"key":"BF1704594_CR15","first-page":"49","volume":"9","author":"V Ratanatharathorn","year":"1992","unstructured":"Ratanatharathorn V, Karanes C, Lum LG et al. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC). Bone Marrow Transplant 1992; 9: 49\u201355.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704594_CR16","first-page":"343","volume":"11","author":"JP Uberti","year":"1999","unstructured":"Uberti JP, Cronin S, Ratanatharathorn V . Optimal use of tacrolimus in the prophylaxis of graft-versus-host disease. Bio Drugs 1999; 11: 343\u2013358.","journal-title":"Bio Drugs"},{"key":"BF1704594_CR17","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704594_CR18","first-page":"250","volume":"28","author":"KM Sullivan","year":"1991","unstructured":"Sullivan KM, Agura E, Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250\u2013259.","journal-title":"Semin Hematol"},{"key":"BF1704594_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF1704594_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statist Med 1999; 18: 695\u2013706.","journal-title":"Statist Med"},{"key":"BF1704594_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/sj.bmt.1700745","volume":"19","author":"T Ruutu","year":"1997","unstructured":"Ruutu T, Niederwieser D, Gratwohl A, Apperley JF . A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant 1997; 19: 759\u2013764.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704594_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJM198603203141201","volume":"314","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729\u2013735.","journal-title":"N Engl J Med"},{"key":"BF1704594_CR23","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","volume":"80","author":"RA Nash","year":"1992","unstructured":"Nash RA, Pepe MS, Storb R et al. Acute graft versus host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838\u20131845.","journal-title":"Blood"},{"key":"BF1704594_CR24","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/sj.bmt.1701510","volume":"22","author":"AC Vigorito","year":"1998","unstructured":"Vigorito AC, Azevedo VM, Marques JFC et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematologic malignancies. Bone Marrow Transplant 1998; 22: 1145\u20131151.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704594_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","volume":"18","author":"D Blaise","year":"2000","unstructured":"Blaise D, Kuentz M, Fortanier C et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 2000; 18: 537\u2013546.","journal-title":"J Clin Oncol"},{"key":"BF1704594_CR26","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","volume":"355","author":"R Powles","year":"2000","unstructured":"Powles R, Mehta J, Kulkarni S et al. Allogeneic blood and bone marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000; 355: 1231\u20131237.","journal-title":"Lancet"},{"key":"BF1704594_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin P, Storer B et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic malignancies. N Engl J Med 2001; 344: 175\u2013181.","journal-title":"N Engl J Med"},{"key":"BF1704594_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.bmt.1701983","volume":"24","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Khouri I, Ueno NT et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. Bone Marrow Transplant 1999; 24: 763\u2013768.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704594_CR29","first-page":"3702","volume":"95","author":"RE Champlin","year":"2000","unstructured":"Champlin RE, Schmitz N, Horowitz MM et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000; 95: 3702\u20133709.","journal-title":"Blood"},{"key":"BF1704594_CR30","first-page":"555","volume":"17","author":"I Majolino","year":"1996","unstructured":"Majolino I, Saglio G, Scime R et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1996; 17: 555\u2013560.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704594_CR31","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1182\/blood.V98.6.1695","volume":"98","author":"D Przepiorka","year":"2001","unstructured":"Przepiorka D, Anderlini P, Saliba R et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001; 98: 1695\u20131700.","journal-title":"Blood"},{"key":"BF1704594_CR32","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","volume":"19","author":"C Cutler","year":"2001","unstructured":"Cutler C, Giri S, Jeyapalan S et al. Acute and chronic graft-versus-host disease after allogeneic peripheral blood stem cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685\u20133691.","journal-title":"J Clin Oncol"},{"key":"BF1704594_CR33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"key":"BF1704594_CR34","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1182\/blood.V100.9.3128","volume":"100","author":"M Mohty","year":"2002","unstructured":"Mohty M, Kuentz M, Michallet M et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 2002; 100: 3128\u20133134.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704594","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:50:52Z","timestamp":1648079452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,26]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9,1]]}},"alternative-id":["BF1704594"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704594","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,26]]},"assertion":[{"value":"25 September 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}